Correlation of plasma osteoprotegerin (OPG) and receptor activator of the nuclear factor κB ligand (RANKL) levels with clinical risk factors in patients with advanced carotid atherosclerosis

BACKGROUND: Osteoprotegerin (OPG) is considered to be a crucial regulatory mediator of bone metabolism by acting as a decoy receptor of the receptor activator of nuclear factor κB ligand (RANKL). OPG and RANKL have further become the subject of intense interest for their potential role in cardiovasc...

Descripción completa

Detalles Bibliográficos
Autores principales: Giaginis, Constantinos, Papadopouli, Aikaterini, Zira, Athina, Katsargyris, Athanasios, Klonaris, Christos, Theocharis, Stamatios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2012
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560555/
https://www.ncbi.nlm.nih.gov/pubmed/23018352
http://dx.doi.org/10.12659/MSM.883485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560555/
https://www.ncbi.nlm.nih.gov/pubmed/23018352
http://dx.doi.org/10.12659/MSM.883485

Ejemplares similares